ALZN

ALZAMEND NEURO INC

ALZN·02262M605·US·Common Stock·Healthcare - Biotechnology-Activist

ALZN (ALZAMEND NEURO INC) is held by 5 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($31,644), VANGUARD FIDUCIARY TRUST CO ($25,224), VANGUARD CAPITAL MANAGEMENT LLC ($9,067). Net institutional sentiment: Bearish.

5
Holders
$69,281
Total Value
20% (5)
Consensus
1 buying - 4 selling
13F: Insider & Congress: Updated regularly
ALZN

Smart Money Verdict

View all
Loading verdict
Held by 5 funds

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Dec 30, 2025 · Activists Oct 7, 2025 · Congress none

InsiderAIAULT MILTON C IIISell $4KDec 23, 2025
InsiderHBHorne William B.Sell $7KDec 19, 2025
InsiderMFMcGrath Lynne FaheySell $68.7Oct 23, 2025
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
26,371(-42.3%)$31,6440.0%-20.56%
0
Unchanged
21,020$25,2240.0%-11.17%
0
Increased
7,556(+71.7%)$9,0670.0%+4.64%
17
Decreased
2,352(-47.8%)$2,8220.0%-15.53%
0
Unchanged
437$5240.0%-84.54%
0
Exited
0(-100.0%)$5,5450.0%-36.17%
0
Exited
0(-100.0%)$19,0800.0%-37.50%
0
ALZNALZNALZAMEND NEURO INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used